Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Frédéric Baron
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Living Beings
Physiology
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
40
Beguin, Yves
24
Fillet, Georges
19
Storb, Rainer
14
Sandmaier, Brenda
13
Frère, Pascale
11
Maloney, David
9
Maris, Michael
9
Baudoux, Etienne
9
Sorror, Mohamed
8
Chauncey, Thomas
6
Schaaf-Lafontaine, Nicole
6
Storer, Barry
5
Herens, Christian
5
Little, Marie-Térèse
5
Castermans, Emilie
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Frédéric Baron (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Baron Frédéric; Petersdorf Effie W; Gooley Ted; Sandmaier Brenda M; Malkki Mari; Chauncey Thomas R; Maloney David G; Storb Rainer
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
-
2008: Sorror Mohamed L; Leisenring Wendy; Mielcarek Marco; Baron Frederic; Diaconescu Razvan; Hogan William J; Graves Scott S; Storb Rainer
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
Transplantation 2008;85(7):1023-9.
-
2008: Lejeune M; Beguin Y; De Prijck B; Fassotte M F; Fillet G; Baron F
[How I treat... Acute myeloid leukemia in older patients with good performance status]
Revue médicale de Liège 2008;63(2):59-63.
-
2008: Castermans Emilie; Baron Frédéric; Willems Evelyne; Schaaf-Lafontaine Nicole; Meuris Nathalie; Gothot André; Vanbellighen Jean-François; Herens Christian; Seidel Laurence; Geenen Vincent; Cheynier Remi; Beguin Yves
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Haematologica 2008;93(2):240-7.
-
2007: Castermans E; Morrhaye G; Marchand S; Martens H; Moutschen M; Geenen V; Beguin Y; Baron F
[Evaluation of thymopoiesis: clinical applications]
Revue médicale de Liège 2007;62(12):725-9.
-
2007: Castermans E; Morrhaye G; Marchand S; Martens H; Moutschen M; Baron F; Beguin Y; Geenen V
[Clinical evaluation of thymic function]
Revue médicale de Liège 2007;62(11):675-8.
-
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
-
2007: Baron Frédéric; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Langston Amelia A; Lange Thoralf; Petersdorf Effie; Bethge Wolfgang; Maziarz Richard T; McSweeney Peter A; Pulsipher Michael A; Wade James C; Chauncey Thomas R; Shizuru Judith A; Sorror Mohamed L; Woolfrey Ann E; Maloney David G; Storb Rainer
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
-
2007: Baron Frédéric; Storb Rainer
Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission.
Current opinion in hematology 2007;14(2):145-51.
-
2007: Baron F; Gothot A
[Mesenchymal stem cells: a new versatile therapeutic option]
Revue médicale de Liège 2007;62 Spec No():9-14.
-
2006: Baron F; Vanstraelen G; Beguin Y
Transfusions after nonmyeloablative or reduced-intensity conditioning regimens.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(12):2081-6.
-
2006: Baron Frédéric; Storer Barry; Maris Michael B; Storek Jan; Piette Fanny; Metcalf Monja; White Kristen; Sandmaier Brenda M; Maloney David G; Storb Rainer; Boeckh Michael
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1176-87.
-
2006: Baron F; Sandmaier B M
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(10):1690-700.
-
2006: Baron Frédéric; Storb Rainer; Storer Barry E; Maris Michael B; Niederwieser Dietger; Shizuru Judith A; Chauncey Thomas R; Bruno Benedetto; Forman Stephen J; McSweeney Peter A; Maziarz Richard T; Pulsipher Michael A; Agura Edward D; Wade James; Sorror Mohamed; Maloney David G; Sandmaier Brenda M
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
-
2006: Baron Frédéric; Sandmaier Brenda M; Zellmer Eustacia; Sorror Mohamed; Storer Barry; Storb Rainer
Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):813-7.
-
2006: Vanstraelen Gaëtan; Baron Frédéric; Willems Evelyne; Bonnet Christophe; Hafraoui Kaoutar; Frère Pascale; Fillet Georges; Beguin Yves
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Experimental hematology 2006;34(7):841-50.
-
2006: Pirson Laurence; Baron Frédéric; Meuris Nathalie; Giet Olivier; Castermans Emilie; Greimers Roland; Di Stefano Ivano; Gothot André; Beguin Yves
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
Stem cells (Dayton, Ohio) 2006;24(7):1814-21.
-
2006: Burroughs Lauri; Mielcarek Marco; Leisenring Wendy; Sandmaier Brenda M; Maloney David G; Baron Frédéric; Martin Paul J; Flowers Mary E D; Forman Stephen J; Chauncey Thomas R; Bruno Benedetto; Storb Rainer
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
-
2006: Frère P; Baron F; Bonnet C; Hafraoui K; Pereira M; Willems E; Fillet G; Beguin Y
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
Bone marrow transplantation 2006;37(4):411-8.
-
2006: Baron Frédéric; Storb Rainer
Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(1):26-41.
-
2005: Baron Frédéric; Sandmaier Brenda M
Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning.
Current opinion in hematology 2005;12(6):435-43.
-
2005: Baron Frédéric; Storb Rainer
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.
Clinical advances in hematology & oncology : H&O 2005;3(10):799-819.
-
2005: Sorror Mohamed L; Maris Michael B; Storb Rainer; Baron Frederic; Sandmaier Brenda M; Maloney David G; Storer Barry
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
-
2005: Vanstraelen Gaëtan; Baron Frédéric; Frère Pascale; Hafraoui Kaoutar; Fillet Georges; Beguin Yves
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
Haematologica 2005;90(9):1269-70.
-
2005: Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
[Nonmyeloablative stem cell transplantation as cancer immunotherapy]
Revue médicale suisse 2005;1(30):1973-7.
-
2005: Diaconescu Razvan; Little Marie-Térèse; Leisenring Wendy; Yunusov Murad; Hogan William J; Sorror Mohamed L; Baron Frédéric; Storb Rainer
What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):335-44.
-
2005: Baron F; Maris M B; Storer B E; Sandmaier B M; Panse J P; Chauncey T R; Sorror M; Little M-T; Maloney D G; Storb R; Heimfeld S
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):822-8.
-
2005: Baron Frédéric; Little Marie-Térèse; Storb Rainer
Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning.
Blood reviews 2005;19(3):153-64.
-
2005: Baron Frédéric; Maris Michael B; Storer Barry E; Sandmaier Brenda M; Stuart Monic J; McSweeney Peter A; Radich Jerald P; Pulsipher Michael A; Agura Edward D; Chauncey Thomas R; Maloney David G; Shizuru Judith A; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
-
2005: Baron Frédéric; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Sorror Mohamed; Diaconescu Razvan; Woolfrey Ann E; Chauncey Thomas R; Flowers Mary E D; Mielcarek Marco; Maloney David G; Storb Rainer
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
-
2004: Baron Frédéric; Baker Jennifer E; Storb Rainer; Gooley Theodore A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Heimfeld Shelly; Oparin Dmitrij; Zellmer Eustacia; Radich Jerald P; Grumet F Carl; Blume Karl G; Chauncey Thomas R; Little Marie-Térèse
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
-
2004: Baron Frédéric; Copizza Sandra; Baudoux Etienne; Jerusalem Guy; Fillet Georges; Beguin Yves
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer.
Haematologica 2004;89(9):1146-8.
-
2003: Baron Frédéric; Schaaf-Lafontaine Nicole; Humblet-Baron Stéphanie; Meuris Nathalie; Castermans Emilie; Baudoux Etienne; Frère Pascale; Bours Vincent; Fillet Georges; Beguin Yves
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Transplantation 2003;76(12):1705-13.
-
2003: Baron Frédéric; Storb Rainer; Little Marie-Térèse
Hematopoietic cell transplantation: five decades of progress.
Archives of medical research 2003;34(6):528-44.
-
2003: Humblet-Baron Stéphanie; Baron Frédéric; Beguin Yves; Chachati Alfred; Bury Jean; Morelon Emmanuel; Kreis Henri
Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Transplantation 2003;76(10):1531-2.
-
2003: Baron Frédéric; Frère Pascale; Fillet Georges; Beguin Yves
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5566-72.
-
2003: Herens Christian; Baron Frédéric; Croisiau Christiane; Tassin Francoise; Bours Vincent
Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.
Cancer genetics and cytogenetics 2003;147(1):78-80.
-
2003: Baron F; Baudoux E; Frère P; Tourqui S; Schaaf-Lafontaine N; Herens C; DePrijck B; Fillet G; Beguin Y
Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC.
Bone marrow transplantation 2003;32(8):829-34.
-
2003: Baron Frédéric; Frère Pascale; Fillet Georges; Beguin Yves
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
British journal of haematology 2003;123(1):103-5.
-
2003: Baron Frederic; Dresse Marie-Françoise; Beguin Yves
Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.
The New England journal of medicine 2003;349(9):913-4.
-
2003: Baron Frédéric; Frère Pascale; Baudoux Etienne; Schaaf-Lafontaine Nicole; Fillet Georges; Beguin Yves
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
Haematologica 2003;88(7):835-7.
-
2003: Baron Frédéric; Frère Pascale; Beguin Yves
Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment.
Haematologica 2003;88(6):718-20.
-
2003: Baron Frédéric; Frère Pascale; Baudoux Etienne; Sautois Brieuc; Fillet Georges; Beguin Yves
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Haematologica 2003;88(4):478-80.
-
2003: Beguin Y; Baron F
Minitransplants: allogeneic stem cell transplantation with reduced toxicity.
Acta clinica Belgica 2003;58(1):37-45.
-
2003: Hafraoui K; Humblet-Baron S; Baron F; Beguin Y; Fillet G
[How I treat...chronic myeloid leukemia]
Revue médicale de Liège 2003;58(1):7-12.
-
2002: Baron Frédéric; Frère Pascale; Herens Christian; Fillet Georges; Beguin Yves
Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Haematologica 2002;87(12):ECR43.
-
2002: Baron F; Fillet G; Beguin Y
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Transplantation 2002;74(12):1692-6.
-
2002: Baron Frédéric; Baudoux Etienne; Fillet Georges; Beguin Yves
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):137-43.
-
2002: Baron Frédéric; Sautois Brieuc; Baudoux Etienne; Matus Geoffrey; Fillet Georges; Beguin Yves
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2002;30(6):546-54.
-
2002: Baron Frédéric; Baudoux Etienne; Frère Pascale; Tourqui Soraya; Schaaf-Lafontaine Nicole; Greimers Roland; Herens Christian; Fillet Georges; Beguin Yves
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
Journal of hematotherapy & stem cell research 2002;11(2):301-14.
-
2002: Baron F; Beguin Y
Nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):243-63.
-
2002: Baron Frédéric; Siquet Jean; Schaaf-Lafontaine Nicole; Baudoux Etienne; Hermanne Jean-Philippe; Fillet Georges; Beguin Yves
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
Haematologica 2002;87(1):78-88.
-
2002: Baron F; Beguin Y
Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):351-9.
-
2000: Baron F; Gothot A; Salmon J P; Hermanne J P; Pierard G E; Fillet G; Beguin Y
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
British journal of haematology 2000;111(3):745-53.
-
2000: Baron F; Dresse M F; Beguin Y
Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease.
Transfusion 2000;40(9):1071-3.
-
2000: Baron F; Ribbens C; Kaye O; Fillet G; Malaise M; Beguin Y
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation.
British journal of haematology 2000;110(2):339-42.
-
2000: Baron F; Beguin Y
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation.
Transfusion 2000;40(4):468-76.
-
1998: Beguin Y; Baron F; Fillet G
Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation.
Haematologica 1998;83(12):1076-81.
-
1998: Daniel C; Baron F; Moutschen M
[Clinical case of the month. Apropos of pancytopenia in a seropositive patient]
Revue médicale de Liège 1998;53(12):732-4.
-
1998: Baron F; Hermanne J P; Fassotte M F; Beguin Y; Fillet G
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]
Revue médicale de Liège 1998;53(11):651-3.
-
1998: Baron F; Sadzot B; Wang F; Beguin Y
Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(2):197-200.
-
1998: Baron F A; Hermanne J P; Dowlati A; Weber T; Thiry A; Fassotte M F; Fillet G; Beguin Y
Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21(9):951-4.
-
1997: Baron F; Deprez M; Beguin Y
The veno-occlusive disease of the liver.
Haematologica 1997;82(6):718-25.
-
1997: Baron F; Beguin Y
[Hepatic complications of chemotherapy. From trivial cytolysis to hepatic veno-occlusive disease]
Revue médicale de Liège 1997;52(2):93-7.
Sign-in to see more
